BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30952744)

  • 1. Hospital Volume Threshold for the Treatment of Retroperitoneal Sarcoma.
    Adam MA; Moris D; Behrens S; Nussbaum DP; Jawitz O; Turner M; Lidsky M; Blazer D
    Anticancer Res; 2019 Apr; 39(4):2007-2014. PubMed ID: 30952744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
    Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
    Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.
    Schmitz R; Adam MA; Blazer DG
    World J Surg Oncol; 2019 Nov; 17(1):180. PubMed ID: 31684956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the Minimum Volume Threshold for Retroperitoneal Soft Tissue Sarcoma Resection: Merging National Data with Consensus Expert Opinion.
    Villano AM; Zeymo A; Chan KS; Shara N; Al-Refaie WB
    J Am Coll Surg; 2020 Jan; 230(1):151-160.e2. PubMed ID: 31672672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall survival after resection of retroperitoneal sarcoma at academic cancer centers versus community cancer centers: An analysis of the National Cancer Data Base.
    Berger NG; Silva JP; Mogal H; Clarke CN; Bedi M; Charlson J; Christians KK; Tsai S; Gamblin TC
    Surgery; 2018 Feb; 163(2):318-323. PubMed ID: 28943041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroperitoneal sarcoma: a 10-year follow-up analysis using hospital-based cancer registry data in Japan.
    Nitta S; Kandori S; Takahashi R; Suzuki S; Hamada K; Tanuma K; Shiga M; Kojo K; Sakka S; Nagumo Y; Hoshi A; Mathis BJ; Negoro H; Okuyama A; Higashi T; Nishiyama H
    Jpn J Clin Oncol; 2024 Jun; 54(6):716-721. PubMed ID: 38411262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality local therapy for retroperitoneal sarcoma.
    Paryani NN; Zlotecki RA; Swanson EL; Morris CG; Grobmyer SR; Hochwald SN; Marcus RB; Indelicato DJ
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1128-34. PubMed ID: 21664065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of surgical quality for retroperitoneal sarcoma: Volume matters.
    Maurice MJ; Yih JM; Ammori JB; Abouassaly R
    J Surg Oncol; 2017 Nov; 116(6):766-774. PubMed ID: 28608360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
    Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
    Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regionalization of Retroperitoneal Sarcoma Surgery to High-Volume Hospitals: Missed Opportunities for Outcome Improvement.
    Villano AM; Zeymo A; McDermott J; Barrak D; Unger KR; Shara NM; Chan KS; Al-Refaie WB
    J Oncol Pract; 2019 Mar; 15(3):e247-e261. PubMed ID: 30550374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.
    Nazzani S; Preisser F; Bandini M; Marchioni M; Tian Z; Soulières D; Montanari E; Ratti D; Acquati P; Briganti A; Shariat SF; Abdollah F; Carmignani L; Karakiewicz PI
    Eur Urol Oncol; 2018 Sep; 1(4):346-351. PubMed ID: 31100257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in Retroperitoneal Soft Tissue Sarcoma Outcomes by Hospital Type: A National Cancer Database Analysis.
    Villano AM; Zeymo A; Chan KS; Unger KR; Shara N; Al-Refaie WB
    JCO Oncol Pract; 2020 Sep; 16(9):e991-e1003. PubMed ID: 32267809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
    Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is long-term survival possible after margin-positive resection of retroperitoneal sarcoma (RPS)?
    Klooster B; Rajeev R; Chrabaszcz S; Charlson J; Miura J; Bedi M; Gamblin TC; Johnston F; Turaga KK
    J Surg Oncol; 2016 Jun; 113(7):823-7. PubMed ID: 27060344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.
    Chen CQ; Yin L; Peng CH; Cai Y; Li YF; Zhao R; Zhou HJ; Li HW
    Chin Med J (Engl); 2007 Jun; 120(12):1047-50. PubMed ID: 17637220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
    MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
    Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.
    Sriussadaporn S; Sriussadaporn S; Pak-art R; Kritayakirana K; Prichayudh S; Samorn P
    J Med Assoc Thai; 2014 Jun; 97(6):598-614. PubMed ID: 25137877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of patients with primary retroperitoneal sarcoma: predictors of outcome from an Australian specialist sarcoma centre.
    Snow HA; Hitchen TX; Head J; Herschtal A; Bae S; Chander S; Chu J; Hendry S; Ngan SY; Desai J; Choong PFM; Henderson M; Gyorki DE
    ANZ J Surg; 2018 Nov; 88(11):1151-1157. PubMed ID: 30288891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.
    Singer S; Corson JM; Demetri GD; Healey EA; Marcus K; Eberlein TJ
    Ann Surg; 1995 Feb; 221(2):185-95. PubMed ID: 7857146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morbidity, mortality and temporal trends in the surgical management of retroperitoneal sarcoma: An ACS-NSQIP follow up analysis.
    Judge SJ; Lata-Arias K; Yanagisawa M; Darrow MA; Monjazeb AM; Kirane AR; Bold RJ; Canter RJ; Canter DJ
    J Surg Oncol; 2019 Sep; 120(4):753-760. PubMed ID: 31355444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.